Annual CFO
-$3.15 M
-$1.32 M-72.03%
December 1, 2023
Summary
- As of February 6, 2025, LIPO annual cash flow from operations is -$3.15 million, with the most recent change of -$1.32 million (-72.03%) on December 1, 2023.
- During the last 3 years, LIPO annual CFO has fallen by -$3.12 million (-10914.69%).
- LIPO annual CFO is now -10914.69% below its all-time high of -$28.60 thousand, reached on December 1, 2020.
Performance
LIPO Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$653.10 K
+$265.70 K+28.92%
September 1, 2024
Summary
- As of February 6, 2025, LIPO quarterly cash flow from operations is -$653.10 thousand, with the most recent change of +$265.70 thousand (+28.92%) on September 1, 2024.
- Over the past year, LIPO quarterly CFO has increased by +$265.70 thousand (+28.92%).
- LIPO quarterly CFO is now -676.58% below its all-time high of -$84.10 thousand, reached on March 1, 2021.
Performance
LIPO Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$3.69 M
+$36.30 K+0.97%
September 1, 2024
Summary
- As of February 6, 2025, LIPO TTM cash flow from operations is -$3.69 million, with the most recent change of +$36.30 thousand (+0.97%) on September 1, 2024.
- Over the past year, LIPO TTM CFO has increased by +$36.30 thousand (+0.97%).
- LIPO TTM CFO is now -4285.26% below its all-time high of -$84.10 thousand, reached on March 1, 2021.
Performance
LIPO TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
LIPO Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -72.0% | +28.9% | +1.0% |
| 3 y3 years | -10000.0% | +28.9% | +1.0% |
| 5 y5 years | -10000.0% | +28.9% | +1.0% |
LIPO Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -218.4% | at low | -182.0% | +53.0% | -272.8% | +1.0% |
| 5 y | 5-year | <-9999.0% | at low | -676.6% | +53.0% | -4285.3% | +1.0% |
| alltime | all time | <-9999.0% | at low | -676.6% | +53.0% | -4285.3% | +1.0% |
Lipella Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$653.10 K(-28.9%) | -$3.69 M(-1.0%) |
| Jun 2024 | - | -$918.80 K(-33.8%) | -$3.72 M(+7.6%) |
| Mar 2024 | - | -$1.39 M(+90.8%) | -$3.46 M(+9.9%) |
| Dec 2023 | -$3.15 M(+72.0%) | -$727.70 K(+5.6%) | -$3.15 M(+18.7%) |
| Sep 2023 | - | -$689.40 K(+5.2%) | -$2.65 M(+16.2%) |
| Jun 2023 | - | -$655.10 K(-39.2%) | -$2.28 M(+3.4%) |
| Mar 2023 | - | -$1.08 M(+365.5%) | -$2.21 M(+20.7%) |
| Dec 2022 | -$1.83 M | -$231.60 K(-27.7%) | -$1.83 M(-11.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$320.20 K(-44.8%) | -$2.07 M(+8.9%) |
| Jun 2022 | - | -$580.00 K(-17.1%) | -$1.90 M(+18.5%) |
| Mar 2022 | - | -$699.40 K(+48.4%) | -$1.60 M(+62.2%) |
| Dec 2021 | -$989.30 K(+3359.1%) | - | - |
| Dec 2021 | - | -$471.20 K(+212.3%) | -$989.30 K(+90.9%) |
| Sep 2021 | - | -$150.90 K(-46.7%) | -$518.10 K(+41.1%) |
| Jun 2021 | - | -$283.10 K(+236.6%) | -$367.20 K(+336.6%) |
| Mar 2021 | - | -$84.10 K | -$84.10 K |
| Dec 2020 | -$28.60 K | - | - |
FAQ
- What is Lipella Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Lipella Pharmaceuticals?
- What is Lipella Pharmaceuticals annual CFO year-on-year change?
- What is Lipella Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Lipella Pharmaceuticals?
- What is Lipella Pharmaceuticals quarterly CFO year-on-year change?
- What is Lipella Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Lipella Pharmaceuticals?
- What is Lipella Pharmaceuticals TTM CFO year-on-year change?
What is Lipella Pharmaceuticals annual cash flow from operations?
The current annual CFO of LIPO is -$3.15 M
What is the all time high annual CFO for Lipella Pharmaceuticals?
Lipella Pharmaceuticals all-time high annual cash flow from operations is -$28.60 K
What is Lipella Pharmaceuticals annual CFO year-on-year change?
Over the past year, LIPO annual cash flow from operations has changed by -$1.32 M (-72.03%)
What is Lipella Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of LIPO is -$653.10 K
What is the all time high quarterly CFO for Lipella Pharmaceuticals?
Lipella Pharmaceuticals all-time high quarterly cash flow from operations is -$84.10 K
What is Lipella Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, LIPO quarterly cash flow from operations has changed by +$265.70 K (+28.92%)
What is Lipella Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of LIPO is -$3.69 M
What is the all time high TTM CFO for Lipella Pharmaceuticals?
Lipella Pharmaceuticals all-time high TTM cash flow from operations is -$84.10 K
What is Lipella Pharmaceuticals TTM CFO year-on-year change?
Over the past year, LIPO TTM cash flow from operations has changed by +$36.30 K (+0.97%)